
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Targeting the transferrin receptor to transport antisense oligonucleotides across the mammalian blood-brain barrier
Scarlett J. Barker, Mai B. Thayer, Chaeyoung Kim, et al.
Science Translational Medicine (2024) Vol. 16, Iss. 760
Closed Access | Times Cited: 19
Scarlett J. Barker, Mai B. Thayer, Chaeyoung Kim, et al.
Science Translational Medicine (2024) Vol. 16, Iss. 760
Closed Access | Times Cited: 19
Showing 19 citing articles:
A combination of systemic mannitol administration and mannitol-modified polyester nanoparticles facilitate gene delivery to the brain through caveolae-mediated endocytosis
Benjamin Gilbert, Chirag Miglani, Arundhati Karmakar, et al.
Molecular Therapy — Nucleic Acids (2025) Vol. 36, Iss. 1, pp. 102480-102480
Open Access | Times Cited: 1
Benjamin Gilbert, Chirag Miglani, Arundhati Karmakar, et al.
Molecular Therapy — Nucleic Acids (2025) Vol. 36, Iss. 1, pp. 102480-102480
Open Access | Times Cited: 1
Metabolic Stability and Targeted Delivery of Oligonucleotides: Advancing RNA Therapeutics Beyond The Liver
Puneet Anand, Yu Zhang, Suraj Patil, et al.
Journal of Medicinal Chemistry (2025)
Open Access
Puneet Anand, Yu Zhang, Suraj Patil, et al.
Journal of Medicinal Chemistry (2025)
Open Access
Durable suppression of seizures in a preclinical model of KCNT1 genetic epilepsy with divalent small interfering RNA
Benjamin J. Andreone, Jennifer S Lin, Jenna Tocci, et al.
Epilepsia (2025)
Open Access
Benjamin J. Andreone, Jennifer S Lin, Jenna Tocci, et al.
Epilepsia (2025)
Open Access
Molecular and cellular characteristics of cerebrovascular cell types and their contribution to neurodegenerative diseases
F. García, Myriam Heiman
Molecular Neurodegeneration (2025) Vol. 20, Iss. 1
Open Access
F. García, Myriam Heiman
Molecular Neurodegeneration (2025) Vol. 20, Iss. 1
Open Access
Running Up that Hill: An Interview with Carole Ho, Denali Therapeutics
Carole Ho, Kevin Davies
GEN Biotechnology (2025)
Closed Access
Carole Ho, Kevin Davies
GEN Biotechnology (2025)
Closed Access
Assessing central nervous system drug delivery
Margareta Hammarlund‐Udenaes, Irena Loryan
Expert Opinion on Drug Delivery (2025)
Closed Access
Margareta Hammarlund‐Udenaes, Irena Loryan
Expert Opinion on Drug Delivery (2025)
Closed Access
A brain-targeted and ROS-responsive natural polysaccharide nanogel for enhancing antidepressant therapy
Dong Xu, Tao Qiao, Yan-Ming Zhou, et al.
Chemical Engineering Journal (2025), pp. 160719-160719
Closed Access
Dong Xu, Tao Qiao, Yan-Ming Zhou, et al.
Chemical Engineering Journal (2025), pp. 160719-160719
Closed Access
Fc-engineered large molecules targeting blood-brain barrier transferrin receptor and CD98hc have distinct central nervous system and peripheral biodistribution
Nathalie Khoury, Michelle E. Pizzo, Claire B. Discenza, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access
Nathalie Khoury, Michelle E. Pizzo, Claire B. Discenza, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access
Comparative Radiotracing Quantifies Brain Cellular Uptake and Catabolism of Bispecific Antibodies Targeting Transferrin Receptor and CD98hc
Jacob L. Veire, Michael J. Lucas, Layne G. Bond, et al.
ACS Chemical Neuroscience (2025)
Closed Access
Jacob L. Veire, Michael J. Lucas, Layne G. Bond, et al.
ACS Chemical Neuroscience (2025)
Closed Access
Targeting Neuroinflammation in Central Nervous System Diseases by Oral Delivery of Lipid Nanoparticles
Yuan Zou, Jing Zhang, Longmin Chen, et al.
Pharmaceutics (2025) Vol. 17, Iss. 3, pp. 388-388
Open Access
Yuan Zou, Jing Zhang, Longmin Chen, et al.
Pharmaceutics (2025) Vol. 17, Iss. 3, pp. 388-388
Open Access
Drug Delivery Across the Blood–Brain Barrier: A New Strategy for the Treatment of Neurological Diseases
Jiao Yang, Lin Yang, Rujuan Wang, et al.
Pharmaceutics (2024) Vol. 16, Iss. 12, pp. 1611-1611
Open Access | Times Cited: 2
Jiao Yang, Lin Yang, Rujuan Wang, et al.
Pharmaceutics (2024) Vol. 16, Iss. 12, pp. 1611-1611
Open Access | Times Cited: 2
Alzheimer's Targeted Treatments: Focus on Amyloid and Inflammation
Takeshi Iwatsubo, Michael C. Irizarry, Joseph W. Lewcock, et al.
Journal of Neuroscience (2023) Vol. 43, Iss. 47, pp. 7894-7898
Open Access | Times Cited: 4
Takeshi Iwatsubo, Michael C. Irizarry, Joseph W. Lewcock, et al.
Journal of Neuroscience (2023) Vol. 43, Iss. 47, pp. 7894-7898
Open Access | Times Cited: 4
An AAV capsid reprogrammed to bind human Transferrin Receptor mediates brain-wide gene delivery
Qin Huang, Ken Y. Chan, Shan Lou, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 4
Qin Huang, Ken Y. Chan, Shan Lou, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 4
Bioanalysis of free antisense oligonucleotide payload from antibody–oligonucleotide conjugate by hybridization LC-MS/MS
Di Jiang, Pei Li, Long Yuan
Bioanalysis (2024), pp. 1-10
Open Access | Times Cited: 1
Di Jiang, Pei Li, Long Yuan
Bioanalysis (2024), pp. 1-10
Open Access | Times Cited: 1
Intravenous administration of blood–brain barrier-crossing conjugates facilitate biomacromolecule transport into central nervous system
Chang Wang, Siyu Wang, Yonger Xue, et al.
Nature Biotechnology (2024)
Closed Access | Times Cited: 1
Chang Wang, Siyu Wang, Yonger Xue, et al.
Nature Biotechnology (2024)
Closed Access | Times Cited: 1
Towards Aptamer-Targeted Drug Delivery to Brain Tumors: The Synthesis of Ramified Conjugates of an EGFR-Specific Aptamer with MMAE on a Cathepsin B-Cleavable Linker
Vladimir A. Brylev, Ekaterina V. Ryabukhina, Evgeniya V. Nazarova, et al.
Pharmaceutics (2024) Vol. 16, Iss. 11, pp. 1434-1434
Open Access
Vladimir A. Brylev, Ekaterina V. Ryabukhina, Evgeniya V. Nazarova, et al.
Pharmaceutics (2024) Vol. 16, Iss. 11, pp. 1434-1434
Open Access
The Emergence of Oligonucleotide Building Blocks in the Multispecific Proximity-Inducing Drug Toolbox of Destruction
K. Zhou, Katherine E. Bujold
ACS Chemical Biology (2024)
Closed Access
K. Zhou, Katherine E. Bujold
ACS Chemical Biology (2024)
Closed Access
Evolution of antisense oligonucleotides: navigating nucleic acid chemistry and delivery challenges
Ruchi Ruchi, Govind Mukesh Raman, Vikas Kumar, et al.
Expert Opinion on Drug Discovery (2024)
Closed Access
Ruchi Ruchi, Govind Mukesh Raman, Vikas Kumar, et al.
Expert Opinion on Drug Discovery (2024)
Closed Access
Engineering considerations for next-generation oligonucleotide therapeutics
Sasha B. Ebrahimi, Himanshu Bhattacharjee, Sujatha Sonti, et al.
Nature Chemical Engineering (2024) Vol. 1, Iss. 12, pp. 741-750
Closed Access
Sasha B. Ebrahimi, Himanshu Bhattacharjee, Sujatha Sonti, et al.
Nature Chemical Engineering (2024) Vol. 1, Iss. 12, pp. 741-750
Closed Access